Current Trends of Hypertension Treatment in the United States

American Journal of Hypertension

Volumn 30, Issue 10, 2017, Pages 1008-1014

  Shah, Shreya J ^a   Stafford, Randall S ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Antihypertensive drugs; Blood pressure; Epidemiology; Hypertension; Prescribing pattern; Prevalence

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BENAZEPRIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; CHLORTALIDONE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HYDROCHLOROTHIAZIDE; IRBESARTAN; LABETALOL; LISINOPRIL; LOSARTAN; METOPROLOL; NEBIVOLOL; NIFEDIPINE; OLMESARTAN; QUINAPRIL; RAMIPRIL; TELMISARTAN; THIAZIDE DIURETIC AGENT; TRIAMTERENE; UNINDEXED DRUG; VALSARTAN; VERAPAMIL;

AGE; ARTICLE; BLOOD PRESSURE REGULATION; CONFIDENCE INTERVAL; DRUG APPROVAL; DRUG UPTAKE; GENDER; HEALTH INSURANCE; HUMAN; HYPERTENSION; PATIENT SELECTION; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RACE; SYSTOLIC BLOOD PRESSURE; UNITED STATES; BLOOD PRESSURE; CLINICAL DECISION MAKING; CLINICAL PRACTICE; DRUG EFFECT; DRUG UTILIZATION REVIEW; FEMALE; HEALTH CARE QUALITY; HEALTH CARE SURVEY; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; TREATMENT OUTCOME; TRENDS;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CLINICAL DECISION-MAKING; DRUG PRESCRIPTIONS; DRUG UTILIZATION REVIEW; FEMALE; HEALTH CARE SURVEYS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PATIENT SELECTION; PRACTICE PATTERNS, PHYSICIANS'; PREVALENCE; PROCESS ASSESSMENT (HEALTH CARE); TREATMENT OUTCOME; UNITED STATES;

EID: 85030640408     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpx085     Document Type: Article

References (29)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289:2560-2572.
2. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell C, Roger V, Sorlie P, Steinberger J, Thom T, Wilson M, Hong Y. Heart disease and stroke statistics: 2008 update at-a-glance. Dallas: American Heart Association, 2008.
3. Vasan RS, Beiser A, Seshadri S, Larson MG, Kannel WB, D'Agostino RB, Levy D. Residual lifetime risk for developing hypertension in middle-aged women and men: The Framingham Heart Study. JAMA 2002; 287:1003-1010.
4. Egan BM, Li J, Hutchison FN, Ferdinand KC. Hypertension in the United States, 1999 to 2012: progress toward Healthy People 2020 goals. Circulation 2014; 130:1692-1699.
5. Yoon SS, Carroll MD, Fryar CD. Hypertension Prevalence and Control Among Adults: United States, 2011-2014. NCHS Data Brief. 2015;(220):1-8.
6. Davis K; Agency for Healthcare Research and Quality Medical Expenditure Panel Survey. Expenditures for Hypertension among Adults Age 18 and Older, 2010: Estimates for the U.S. Civilian Noninstitutionalized Population. 2013. Accessed 27 March 2016.
7. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, Finkelstein EA, Hong Y, Johnston SC, Khera A, Lloyd-Jones DM, Nelson SA, Nichol G, Orenstein D, Wilson PW, Woo YJ; American Heart Association Advocacy Coordinating Committee; Stroke Council; Council on Cardiovascular Radiology and Intervention; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council on Arteriosclerosis; Thrombosis and Vascular Biology; Council on Cardiopulmonary; Critical Care; Perioperative and Resuscitation; Council on Cardiovascular Nursing; Council on the Kidney in Cardiovascular Disease; Council on Cardiovascular Surgery and Anesthesia, and Interdisciplinary Council on Quality of Care and Outcomes Research. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 2011; 123:933-944.
8. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Judd SE, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Mackey RH, Magid DJ, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Mussolino ME, Neumar RW, Nichol G, Pandey DK, Paynter NP, Reeves MJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Wong ND, Woo D, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 2014; 129:e28-e292.
9. Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, Chalmers J, Rodgers A, Rahimi K. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 2016; 387:957-967.
10. Neal B, MacMahon S, Chapman N; Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration. Lancet 2000; 356:1955-1964.
11. Yoon SS, Gu Q, Nwankwo T, Wright JD, Hong Y, Burt V. Trends in blood pressure among adults with hypertension: United States, 2003 to 2012. Hypertension 2015; 65:54-61.
12. Egan BM, Li J, Hutchison FN, Ferdinand KC. Hypertension in the United States, 1999 to 2012: progress toward Healthy People 2020 goals. Circulation 2014; 130:1692-1699.
13. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009; 338:b1665.
14. Rodeheffer RJ. Hypertension and heart failure: the ALLHAT imperative. Circulation 2011; 124:1803-1805.
15. Zhou M, Daubresse M, Stafford RS, Alexander GC. National trends in the ambulatory treatment of hypertension in the United States, 1997-2012. PLoS ONE 2015; 10:e0119292.
16. IMS Health. NDTI Diagnosis Reference File, 2000 to 2014. Plymouth Meeting, PA: IMS Health, 2000 to 2014.
17. Zell ER, McCaig LF, Kupronis BA, Besser RE, Schuchat A. A comparison of the National Disease and Therapeutic Index and the National Ambulatory Medical Care Survey to evaluate antibiotic usage. Proceedings of the section on survey research methods, American Statistical Association. Alexandria, VA American Statistical Association. 2000; 840-845.
18. Stafford RS, Radley DC. National trends in ambulatory asthma treatment, 1997-2009. J Gen Intern Med 2011; 26:1465-1470.
19. Stafford R, Radley D. The underutilization of cardiac medications of proven benefit, 1990 to 2002. J Am Coll Cardiol 2003; 41:56-61.
20. Kirley K, Qato DM, Kornfield R, Stafford RS, Alexander GC. National trends in oral anticoagulant use in the United States, 2007 to 2011. Circ Cardiovasc Qual Outcomes 2012; 5:615-621.
21. IMS Health Incorporated. National Disease and Therapeutic Index. Plymouth Meeting, PA: IMS Health Incorporated, 2004.
22. Beckman KD. How to document and code for hypertensive diseases in ICD-10. Fam Pract Manag 2014; 21:5-9.
23. ICD-9-CM Official Guidelines for Coding and Reporting. Baltimore, MD: Centers for Medicare & Medicaid Services and National Center for Health Statistics. 2011. Accessed 21 September 2016
24. Ashman JJ, Rui P, Schappert SM. Age Differences in Visits to Office-Based Physicians by Adults With Hypertension: United States, 2013. NCHS Data Brief, No 263. Hyattsville, MD: National Center for Health Statistics, 2016.
25. Garrison GM, Oberhelman S. Screening for hypertension annually compared with current practice. Ann Fam Med 2013; 11:116-121.
26. Drugs@FDA: FDA Approved Drug Products. Drugs@FDA: FDA Approved Drug Products. 2016. Accessed 21 September 2016.
27. U.S Department of Health and Human Services-Administration for Community Living. U.S. Population Totals by Age Group and Sex in the 2010 and 2000 Censuses. U.S. Administration on Aging, 2010.
28. US Census Bureau. United States 2010 Census. 2011. Washington, DC. Accessed 20 October 2016.
29. Chang TI, Evans G, Cheung AK, Cushman WC, Diamond MJ, Dwyer JP, Huan Y, Kitzman D, Kostis JB, Oparil S, Rastogi A, Roumie CL, Sahay R, Stafford RS, Taylor AA, Wright JT Jr, Chertow GM; SPRINT Study Research Group. Patterns and correlates of baseline thiazide-type diuretic prescription in the Systolic Blood Pressure Intervention Trial. Hypertension 2016; 67:550-555.